iTonic Holdings Ltd
iTonic Holdings Ltd is a U.S.-listed healthcare solutions company organized around Beijing Feitian Zhaoye Technology Co., Ltd., its wholly owned operating subsidiary in Beijing, China. The company develops treatment planning systems and related products and services for brachytherapy, a targeted radiation therapy used in cancer treatment.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2022–2025
Liiketoiminta
Osuus liikevaihdostaSoftware and systems used to plan brachytherapy procedures and treatment delivery.
Products used alongside brachytherapy treatment planning and execution.
Implementation, support, and related services for customers using the company’s systems.
Tuotteet
Raportoitu · osuus liikevaihdosta- Sales of FTTPS69,4 %
- Sales of Medical Auxiliary Supplies30,6 %
Lähde: 20-F/A FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.
Asiakkaat
The company sells to healthcare providers involved in cancer treatment, especially institutions that perform brachytherapy planning and delivery. Its buyers need specialized planning tools to support safe, targeted radiation therapy workflows and to standardize treatment across tumor applications.
Buy treatment planning systems for brachytherapy procedures and clinical workflow support.
Use the company’s planning tools to support targeted cancer treatment delivery.
May purchase related products and services that support deployment and use of the systems.
Strategia
The company’s stated direction is to build around brachytherapy treatment planning and expand the use of its products across multiple malignant tumor applications. Its strategy appears centered on leveraging the installed clinical workflow around its planning system while broadening market acceptance for related offerings.
Wider adoption increases the addressable base for the company’s core system.
Related products and services can deepen customer relationships and usage.
As a U.S.-listed foreign issuer, market access supports operating flexibility.
Maantiede
iTonic is legally domiciled in the United States and trades on Nasdaq, but its operating subsidiary and principal business base are in Beijing, China. The reports identify Beijing as the company’s operational center, which makes the business exposed to China-based regulatory, commercial, and operating conditions. The dual U.S.-listing and China operating footprint also shape how the company accesses capital and serves customers.
Riskit
The company faces clinical-adoption risk because its products address a specialized cancer-treatment workflow that must gain acceptance from hospitals and physicians. It also carries U.S.-listed foreign issuer risk, including Nasdaq compliance, cross-border operating exposure, and the need to maintain access to capital while conducting business through a China-based subsidiary.
- Nasdaq minimum bid price complianceVaikutus: KorkeaTodennäköisyys: Korkea
Failure to regain compliance can trigger delisting proceedings and reduce market access.
Kohdistuu: Class A ordinary shares
- Clinical adoption of brachytherapy planning systemsVaikutus: KorkeaTodennäköisyys: Kohtalainen
Demand depends on healthcare providers adopting a specialized treatment workflow.
Kohdistuu: Treatment planning system sales
- China operating and regulatory exposureVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Operations are centered in Beijing through a Chinese subsidiary and may be affected by local rules.
Kohdistuu: Beijing subsidiary and customer base
- Foreign issuer capital-market riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen
The company depends on public-market access for funding and investor visibility.
Kohdistuu: Nasdaq-listed structure
Kirjanpito
Harkinnanvaraiset erätProducts and related services may be delivered at different times, affecting reported revenue timing.
Vaikutus: Bundled contracts can shift revenue between periods
Healthcare customer collections may require judgment over recoverability.
Vaikutus: Could affect bad debt expense and net assets
Specialized technology businesses may need impairment testing if usage or demand weakens.
Vaikutus: Can create non-cash charges if carrying values exceed recoverable amounts
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Vivos Inc
RDGL · Surgical & Medical Instruments & Apparatus
Burning Rock Biotech Ltd
BNR · Services-Medical Laboratories
Burning Rock Biotech Ltd is a precision oncology company focused on applying next-generation sequencing to cancer care.
NeOnc Technologies Holdings, Inc
NTHI · Pharmaceutical Preparations
Zhongchao Inc.
ZCMD · Services-Educational Services
Wetouch Technology Inc.
WETH · Computer Peripheral Equipment, NEC
Longduoduo Co Ltd
LDDD · Services-Health Services
Longduoduo Co Ltd is a U.S.-listed company with operating subsidiaries in Inner Mongolia and Beijing that generates revenue from two main activities: direct…
Päivitetty: 28.9.2026